This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Dr. Reddy's Laboratories, Incorporated. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Venkata Madhubabu Meesala: Innovator in Pharmaceutical Chemistry
Introduction
Venkata Madhubabu Meesala is a notable inventor based in Kakinada, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of important compounds. His work is characterized by a focus on innovative processes that enhance the efficiency and effectiveness of chemical production.
Latest Patents
Venkata Madhubabu Meesala holds a patent for a process for producing (S)-equol. The patent details an improved method for the preparation of (S)-equol, along with novel intermediates that facilitate its synthesis. This advancement is crucial for the pharmaceutical industry, as (S)-equol has various applications in health and wellness.
Career Highlights
He is currently employed at Dr. Reddy's Laboratories, Incorporated, a leading global pharmaceutical company. His role involves research and development, where he applies his expertise to create innovative solutions in drug formulation and synthesis. His dedication to advancing pharmaceutical science is evident in his work and contributions to the field.
Collaborations
Venkata Madhubabu Meesala has collaborated with esteemed colleagues such as Vilas Hareshwar Dahanukar and Syam Kumar Unniaran Kunhimon. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective projects.
Conclusion
Venkata Madhubabu Meesala is a prominent figure in the realm of pharmaceutical innovation. His contributions, particularly in the synthesis of (S)-equol, highlight his commitment to advancing chemical processes. His work at Dr. Reddy's Laboratories continues to impact the industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
